IGES acquires majority stake in UK consulting firm Optimax Access Ltd

Continuation of the European growth of the IGES Group - Expansion of life science services for international customers

Berlin, November 4th 2019 (IGES Institut) – The IGES Group continues its European growth. The most recent acquisition is the majority of the shares in the British consulting firm Optimax Access Ltd, based in Southampton (U.K.), which specialises in health economic consulting for manufacturers of pharmaceuticals and medical devices.

In March 2019, the first British company, Device Access Ltd., a medical technology consulting company, was integrated into the network. IGES Director Professor Bertram Häussler says: "With two highly specialised British companies, the IGES Group is a strong partner for the life sciences industry, which sees the UK as an important docking point for health markets both within and outside Europe. The acquisition of Optimax Access also reflects the growing importance of health economic analysis in bringing innovation to the market".

Optimax Access founder Dr. Mehdi Javanbakht will continue to manage the company as CEO. Dr. Mehdi Javanbakht said: "The services of Optimax Access and the IGES Group complement each other ideally and open up further growth. We are also united by the goal of providing strategic consulting at the highest methodological and scientific level.

About Optimax Access:
Optimax Access Ltd is a young consultancy organisation for Health Economics and Outcome Research (HEOR) based in the UK with a worldwide network of specialists. It supports the development of market access, pricing and reimbursement strategies for pharmaceutical and medical devices companies.

About IGES:
The IGES Institute, founded in 1980, is the core of the IGES group and has become one of Germany’s most important voices for the health care sector. IGES offers creative solutions for questions in care, quality, financing and shaping competition for all actors in the life sciences arena. Clients are government organizations, providers, NGOs and companies. The institute has conducted over 2,000 research and consulting projects since its foundation.

Contacts:

IGES Institut GmbH
Sandra Jessel
Press officer
Tel.: +49 (0) 30 23 08 09 411
Email: Sandra.Jessel@iges.com
www.igeslifescience.com
www.iges.com

Optimax Access Ltd
Dr. Mehdi Javanbakht
Kenneth Dibben House, Enterprise Rd
Chilworth, Southampton Science Park
Southampton SO16 7NS, England
Tel: +44 (7546) 456414
Email: info@Optimaxaccess.com